PROLOGUE
Live / Applied — Third extension granted (statement of use) (as of 20 Feb 2026)
What this means for you
Not registered yet, but its 21 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97900529
- Mark type
- Stylized text
- Filed
- 21 Apr 2023
- Published for opposition
- 25 Jun 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo skeletal and genitourinary systems, and viruses and infectious diseases
Owner
- PROLOGUE MEDICINES, INC., CAMBRIDGE, MA, US
- PROLOGUE MEDICINES, INC., CAMBRIDGE, MA, US
- Flagship Labs 89, Inc., Cambridge, MA, US
Prosecution history
- 23 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 20 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Feb 2026 — SOU EXTENSION 3 GRANTED
- 20 Feb 2026 — SOU EXTENSION 3 FILED
- 20 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 16 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Aug 2025 — SOU EXTENSION 2 GRANTED
- 15 Aug 2025 — SOU EXTENSION 2 FILED
- 15 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — SOU EXTENSION 1 GRANTED
- 13 Feb 2025 — SOU EXTENSION 1 FILED
- 13 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED